The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Plasma genotyping of patients enrolled on the expansion phase I/II trial of X-396 in patients (pts) with ALK+ non-small cell lung cancer (NSCLC).
 
Leora Horn
Honoraria - Biodesix
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Genentech; Merck; Puma Biotechnology; Xcovery
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst)
 
Heather A. Wakelee
Honoraria - ACEA Biosciences; Biocon; Helsinn Therapeutics; Peregrine Pharmaceuticals; Pfizer
Consulting or Advisory Role - ACEA Biosciences; Helsinn Therapeutics; Peregrine Pharmaceuticals; Pfizer
Research Funding - Agennix (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Clovis Oncology (Inst); Exelixis (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst); Xcovery (Inst)
Travel, Accommodations, Expenses - ACEA Biosciences; Clovis Oncology; Novartis; Pfizer
 
Karen L. Reckamp
Consulting or Advisory Role - Amgen; ARIAD; Astellas Pharma; Boehringer Ingelheim
Research Funding - Adaptimmune; ARIAD; Astellas Pharma; Bristol-Myers Squibb; Clovis Oncology; Eisai; Gilead Sciences; GlaxoSmithKline; Novartis; Pfizer; Pfizer; Xcovery
 
George R. Blumenschein
Consulting or Advisory Role - Abbvie; Bayer; Bristol-Myers Squibb; Celgene; Clovis Oncology; Merck
Research Funding - AstraZeneca; Bayer; Bristol-Myers Squibb; Novartis; Xcovery
 
Jeffrey R. Infante
No Relationships to Disclose
 
Corey Allan Carter
Honoraria - Bristol-Myers Squibb
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
 
Saiama Naheed Waqar
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Lilly (Inst); Newlink Genetics (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Spectrum Pharmaceuticals (Inst); Synermore biologics (Inst); Vertex (Inst); Xcovery (Inst)
 
Joel W. Neal
Consulting or Advisory Role - Boehringer Ingelheim; CARET; Clovis Oncology; Nektar
Research Funding - ArQule; Boehringer Ingelheim; Exelixis; Genentech/Roche; Merck; Nektar; Novartis
 
Jon P Gockerman
Employment - Novella Clinical
 
Kimberly Harrow
Employment - Xcovery
Leadership - Xcovery
Travel, Accommodations, Expenses - Xcovery
 
Gary Dukart
Employment - Xcovery
Travel, Accommodations, Expenses - Xcovery
 
Chris Liang
Employment - Tyrogenex; Xcovery
Leadership - Tyrogenex; Xcovery
Stock and Other Ownership Interests - Tyrogenex; Xcovery
 
James J. Gibbons
Employment - Xcovery
Leadership - Xcovery
Stock and Other Ownership Interests - Xcovery
 
Jennifer Hernandez
Employment - Resolution Bioscience
 
Tara Newman-Eerkes
Employment - Resolution Bioscience
 
Lee Lim
Employment - Resolution Bioscience
 
Christine Marie Lovly
Honoraria - Harrison and Star; Novartis; Sequenom
Consulting or Advisory Role - ARIAD; Clovis Oncology; Genoptix; Novartis; Pfizer
Speakers' Bureau - Abbott Molecular; Qiagen
Research Funding - AstraZeneca; Novartis